Page last updated: 2024-08-16

resveratrol and risperidone

resveratrol has been researched along with risperidone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Li, P; Liu, X; Wang, J; Wang, Y; Yang, L; Zheng, L; Zhou, H; Zhou, Z1
Azirak, S; Bilgic, S; Guvenc, AN; Kocaman, N; Ozer, MK; Tastemir Korkmaz, D1
Akhondzadeh, S; Hendouei, F; Mohammadi, MR; Rezaei, F; Sanjari Moghaddam, H; Taslimi, N1
Akhondzadeh, S; Alikhani, R; Ashraf-Ganjouei, A; Bagheri, S; Moradi, K; Mousavi, SB; Rezaei, F; Samaei, A1

Trials

2 trial(s) available for resveratrol and risperidone

ArticleYear
Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial.
    Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:2

    Topics: Antipsychotic Agents; Autism Spectrum Disorder; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Irritable Mood; Male; Neuroprotective Agents; Resveratrol; Risperidone; Treatment Outcome

2020
Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial.
    The international journal of neuropsychopharmacology, 2020, 12-29, Volume: 23, Issue:12

    Topics: Adult; Antioxidants; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Resveratrol; Risperidone; Schizophrenia

2020

Other Studies

4 other study(ies) available for resveratrol and risperidone

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Atypical antipsychotics induce human osteoblasts apoptosis via Wnt/β-catenin signaling.
    BMC pharmacology & toxicology, 2019, Feb-12, Volume: 20, Issue:1

    Topics: Amisulpride; Antipsychotic Agents; Apoptosis; Aripiprazole; beta Catenin; Cell Line; Humans; Olanzapine; Osteoblasts; Resveratrol; Risperidone; Wnt Signaling Pathway

2019
The protective effect of resveratrol against risperidone-induced liver damage through an action on FAS gene expression.
    General physiology and biophysics, 2019, Volume: 38, Issue:3

    Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; fas Receptor; Female; Liver; Protective Agents; Rats; Rats, Sprague-Dawley; Resveratrol; Risperidone

2019